Market Overview

UPDATE: Morgan Stanley Reiterates On CIGNA As 4Q Issues May Linger

Share:
Related CI
Express Scripts' Potential Breakup With Anthem, Explained
David Einhorn's Letter To Greenlight Investors Reveals New Perrigo Position
Zombie TrumpCare Is Back, But These Health Insurer Stocks Are Breaking Out (Investor's Business Daily)

In a report published Friday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on CIGNA (NYSE: CI), but lowered the price target from $100.00 to $93.00.

In the report, Morgan Stanley noted, “Issues CI experienced in 4Q may spill over into 2014 results. However, >$1.5B in deployable cash in FY14 and improvements in 2H14 should yield mid single-digit EPS growth. Our adjusted EPS of $7.16 reflects 6% Y/Y growth off a lower 2013 platform.”

CIGNA closed on Friday at $76.14.

Latest Ratings for CI

DateFirmActionFromTo
Apr 2017Deutsche BankInitiates Coverage OnBuy
Mar 2017Bank of AmericaInitiates Coverage OnBuy
Feb 2017RBC CapitalUpgradesSector PerformOutperform

View More Analyst Ratings for CI
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (CI)

View Comments and Join the Discussion!